Patients New Evidation CEO to double down on patient data empowerment pharmaphorum spoke with Leslie Oley Wilberforce, Evidation's new CEO, about the company's unique approach to real-world data and her future plans.
Digital JP Morgan Week 2025 – Phil Johnson Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.
R&D Inside the new world of healthcare data These days, real-world data collection is in vogue and not hard to come by in healthcare research.
Sales & Marketing Next generation patient engagement and enriched insights Increasing Confidence in Person-Generated Health Data (PGHD) and its Impact on Clinical Decision Making
Market Access How do we make patient centricity a reality? For years, the subject of fostering direct connections with patients has been highlighted by notable figures across the healthcare and life sciences industries as a key feature to be explor
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.